46.53USD-4.91%Mkt Cap: 2.63B $P/E: —Today
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a pro…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap2.63B $
Enterprise Value2.41B $
Revenue (TTM)251.17M $
Gross Profit167.35M $
Net Income (TTM)-15.70M $
Revenue/Share5.071 USD
Last Price46.53 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees622
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)67.17
PEG99.04
EV/EBITDA-403.04
EV/Revenue9.58
P/S9.94
P/B9.72
EPS (TTM)-0.64
EPS (Forward)0.69
52W Range
13.6489% of range50.62
52W High50.62 USD
52W Low13.64 USD
Profitability
Gross Margin74.31%
Oper. Margin-3.09%
EBITDA Margin-2.38%
Profit Margin-6.97%
ROE-12.19%
ROA-7.08%
Growth
Revenue Growth23.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF812.00K $
CapEx (TTM)5.59M $
FCF Margin7.26%
FCF Yield0.69%
Net Debt-91.35M $
Net Debt/EBITDA15.31
Balance Sheet
Debt/Equity0.52
Current Ratio6.60
Quick Ratio4.79
Book Value/Sh4.776 USD
Cash/Share2.072 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJan 27, 2010
Pay DateFeb 12, 2010
Splits
Last Split105:100
Split DateJul 11, 1994
Analyst Consensus
Rating—
Target (Mean)53.22 USD
Upside (mean)+14.4%
Target Range48.00 USD – 58.00 USD
$48.00+14.4% to mean$58.00
# Analysts9
Ownership
Shares Out.53.76M
Float52.62M
Insiders2.16%
Institutions99.10%
Short Interest
Short Ratio3.0d
Short % Float8.75%
Short % Out.7.57%
Shares Short4.07M
Short (prev mo.)4.63M
Technical
SMA 5043.82 (+6.2%)
SMA 20036.11 (+28.9%)
Beta1.14
S&P 52W Chg18.16%
Avg Vol (30d)1.08M
Avg Vol (10d)802.33K
Technical Indicators
RSI (14)66.1
MACD1.9528
MACD Signal1.4605
MACD Hist.+0.4924
BB Upper52.09 USD
BB Middle44.74 USD
BB Lower37.39 USD
BB Width32.86%
ATR (14)2.190 USD
Vol Ratio (20d)0.98x